The effect of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) as an adjuvant in patients with resectable pancreatic cancer

Figures & data

Table 1. General characteristics of 33 patients with pancreatic cancer.

	No of patients	%
Male/female	14/19	42.4/57.6
Tumour anatomic distribution
Head	26	78.8
Body	2	6.1
Tail	4	12.1
Mixed	1	3
Performance status
90–100%	25	75.8
70–80%	7	21.2
50–60%	1	3
Tumour infiltration
T1	2	6.1
T2	3	9.1
T3	28	84.8
Nodal infiltration
N0	13	39.4
N1	20	60.6
Degree of differentiation
G1	6	18.2
G2	18	54.5
G3	9	27.3
TNM stage
I	4	12.1
II	9	27.3
III	20	60.6

Table 2. Postoperative complications.

	No. of patients	%
Postoperative bleeding	1	3
Acute respiratory distress syndrome	2	6.1
Anastomotic leak	3	9.1
Sepsis	1	3
Grade II neutropenia	1	3

Figure 1. Overall survival in 33 patients with pancreatic carcinomas undergoing R₀ resection in combination with HIPEC